Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Andreas Bhagwani | M | 49 |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | 11 years |
Caroline Lundgren Brandberg | F | 45 |
University of Stockholm
| 3 years |
Roger Glen Berlin | M | 74 |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | 7 years |
Robert Taflin | M | 55 |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | 11 years |
Tuula Teeri | M | 67 |
University of Stockholm
| - |
Ola Wiklund | M | - |
University of Stockholm
| - |
Sangwoo Lee | M | 52 |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | 5 years |
Björn Klasson | M | 72 |
University of Stockholm
| - |
Anki Bystedt | F | 57 |
University of Stockholm
| - |
Mattias Giovanni Fili | M | - |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | 11 years |
Maarten de Château | M | 61 |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | 7 years |
Eva Birgitta Swartz Grimaldi | F | 68 |
University of Stockholm
| - |
Hans Andreasson | M | 59 |
University of Stockholm
| 8 years |
Jessica Östberg | M | - |
University of Stockholm
| - |
Lars Nyberg | M | 73 |
University of Stockholm
| 18 years |
Armando Córdova | M | 54 |
University of Stockholm
| - |
Klaus Olle Alfred Gottwald | M | 73 |
University of Stockholm
| - |
Eric Hjalmar Walum | M | 79 |
University of Stockholm
| - |
Mats Bo Johan Nilsson Bernitz | M | 54 |
University of Stockholm
| - |
Pär Lars Gellerfors | M | 77 |
University of Stockholm
| 41 years |
Saeid Esmaeilzadeh | M | 50 |
University of Stockholm
| 22 years |
Anders Olof Adolf Ekblom | M | 70 |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | 2 years |
Carl-Johan Spak | M | 68 |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | 7 years |
Staffan Josephson | M | 75 |
University of Stockholm
| - |
Ove Henning Mattsson | M | 84 |
University of Stockholm
| - |
Bertil Samuelsson | M | 74 |
University of Stockholm
| - |
Alexandra Ekman Ryding | M | - |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | 6 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Tomas Therén | M | 51 |
University of Stockholm
| 29 years |
Albin Axelsson | M | - |
University of Stockholm
| 5 years |
Eric Andersson | M | - |
University of Stockholm
| 4 years |
Philip Reznik | M | - |
University of Stockholm
| 6 years |
Carl Sörnäs | M | - |
University of Stockholm
| 3 years |
Patrik Stockhaus | M | - |
University of Stockholm
| 2 years |
Marith Welin-Berger | M | - |
University of Stockholm
| 5 years |
Pontus Lund | M | - |
University of Stockholm
| 3 years |
Irene Ardenstedt | F | - |
University of Stockholm
| 3 years |
Christoffer Ahnemark | M | - |
University of Stockholm
| 3 years |
Denice Carbell | F | - |
University of Stockholm
| 3 years |
Johan Carlsson | M | - |
University of Stockholm
| 4 years |
Areskog Bjorn | M | - |
University of Stockholm
| 5 years |
Mehdi Lahlou | M | - |
University of Stockholm
| 3 years |
Kajsa Tesch Morawetz | F | - |
University of Stockholm
| 5 years |
Kaspar Hållsten | M | - |
University of Stockholm
| 4 years |
Sara Bechor | F | - |
University of Stockholm
| 4 years |
Gabriel Gilis | M | - |
University of Stockholm
| 2 years |
Michael Sparring | M | - |
University of Stockholm
| 2 years |
Philip Mesch | M | - |
University of Stockholm
| 4 years |
Patrik Tigerschiold | M | 60 |
University of Stockholm
| 4 years |
Benjamin Zeitoun | M | - |
University of Stockholm
| 1 years |
David Östman | M | - |
University of Stockholm
| 4 years |
Johan Eklund | M | - |
University of Stockholm
| 3 years |
Åsa Inde | F | 64 |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | - |
Jens Olof Henriksson | M | 57 |
University of Stockholm
| 4 years |
Frida Karlsson | F | 40 |
University of Stockholm
| 3 years |
Zacharias Karlsen | M | - |
University of Stockholm
| 4 years |
Dave Messina | M | - |
University of Stockholm
| 5 years |
Moritz Dufner | M | - |
University of Stockholm
| 2 years |
Helena Caan Mattsson | F | 37 |
University of Stockholm
| 1 years |
Sonia Yosef | F | - |
University of Stockholm
| 4 years |
Alm Erika | F | - |
University of Stockholm
| 3 years |
Alexander Winqvist | M | 35 |
University of Stockholm
| 5 years |
Henrik Hartman | M | - |
University of Stockholm
| 2 years |
TEd Arffman | M | - |
University of Stockholm
| 3 years |
Kevin Kunze | M | - |
University of Stockholm
| 2 years |
Sandra Malmberg | F | - |
University of Stockholm
| 3 years |
Rasmus Bergström | M | - |
University of Stockholm
| 2 years |
Anja Wik | F | - |
University of Stockholm
| 4 years |
Anton Cederling | M | - |
University of Stockholm
| 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
Sweden | 68 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Tore Bengtsson
- Personal Network